Neonatal Medicine

The Korean Society of Neonatology (대한신생아학회)
권호 표지

Association between Ureaplasma urealyticum Colonization and Adverse Outcomes in Premature Infants

출생 시 Ureaplasma urealyticum 집락이 조산아의 임상 양상에 미치는 영향

  • Yun, Jin-Sang (Department of Pediatrics, CHA Bundang Medical Center, CHA University) ;
  • Chang, Sun-Jung (Department of Pediatrics, CHA Bundang Medical Center, CHA University) ;
  • Jo, Heui-Seung (Department of Pediatrics, CHA Bundang Medical Center, CHA University) ;
  • Lee, Kyu-Hyung (Department of Pediatrics, CHA Bundang Medical Center, CHA University)
  • 윤진상 (CHA 의과학대학교 소아과학교실) ;
  • 장선정 (CHA 의과학대학교 소아과학교실) ;
  • 조희승 (CHA 의과학대학교 소아과학교실) ;
  • 이규형 (CHA 의과학대학교 소아과학교실)
  • Published : 2009.05.31

⟨ Previous Next ⟩

Abstract

Purpose: Present evidences suggest that Ureaplasma urealyticum is a cause of pneumonia, septicemia, and bronchopulmonary dysplasia (BPD) in newborn infants, particularly those born prematurely. The purpose of this work was to examine the relationship between Ureaplasma urealyticum in the tracheal aspirates and adverse outcomes, such as BPD and early onset neonatal sepsis in premature infants. Methods: A polymerase chain reaction (PCR) was performed on tracheal aspirates collected within 24 hour after birth in 176 premature infants less than 35 weeks of gestation and admitted to the neonatal intensive care unit of Bundang CHA Hospital. Results: U. urealyticum was detected in 37 of 176 preterm infants (21.0%). Gestational age ($29^{+5}{\pm}2^{+5}$ wk vs. $30^{+6}{\pm}2^+{-5}$ wk, P=0.0l3) and birth weight (1.39${\pm}$0.44 kg vs. 1.59${\pm}$0.55 kg, P=0.037) were lower in the U urealyticum-positive group compared to the control group. The incidence of early onset neonatal sepsis (16.2% vs. 6.5%, P=0.045) and BPD (45.9% vs. 29.5%, P=0.047) was higher in the U urealyticum-positive group compared to the control group, but the severity of BPD was not different between two groups. However, multiple logistic regression analysis revealed that the presence of U. urealyticum was not independently related to the development of early onset neonatal sepsis and BPD. Conclusion: The results suggest that colonization of the lower respiratory tract by U. urealyticum might not be related to the development of neonatal sepsis and BPD directly in preterm infants.

목적 : Urea plasma urealyticum (U. urealyticum) 집락은 조산아의 주산기 사망, 폐렴, 패혈증 및 기관지폐 형성이상과 관련이 있는 것으로 알려져 왔다. 출생 시 하부기도의 U. urealyticum 집락 여부가 조산아의 기관지폐 형성이상과 조발형 패혈증의 발생과 관련이 있는지 알아보기 위하여 본 연구를 시도하였다. 방법 : 2006년 9월부터 2008년 12월까지 분당차병원 신생아 집중치료실에 입원하여 인공 환기 치료를 받았던 35주 미만의 미숙아 176례를 대상으로 하였다. U. urealyticum 은 생후 24시간 이내의 기관흡인액을 중합 효소연쇄반응법으로 검사하였다. 기관지폐 형성이상은 Jobe와 Bancalari에 의한 분류법에 따라 정의하였고, 경증, 중등도, 중증으로 분류하였다. 결과 : 176례 중 37례에서 U. urealyticum 양성으로 21.0%의 양성률을 보였다. U. urealyticum 양성군에 재태연령($29^{+5}{\pm}2^{+5}$주 vs. $30^{+6}{\pm}2^+{-5}$, P=0.013)과 출생체중 (1.39${\pm}$0.44 kg vs. 1.59${\pm}$0.55 kg, P=0.037)이 U. urealyticum 음성군보다 낮았다. 조발형 패혈증(16.2% vs. 6.5%, P=0.045)과 기관지폐 형성이상(45.9% vs. 29.5%, P=0.04)의 발생빈도는 U. urealyticum 양성군에서 유의하게 높았으나, 기관지폐 형성이상의 중증도는 두 군 간의 차이를 보이지 않았다. 재태연령 등의 다양한 변수의 영향을 보정한 분석 결과 U. urealyticum 집락 양성과 조발형 패혈증과 기관지폐 형성이상의 발생사이의 연관성은 관찰되지 않았다. 결론 : 본 연구결과는 출생시 하부 기도의 U. urealyticum 집락이 조산아의 패혈증과 기관지폐이형성증의 발생에 직접적인 관련성은 없음을 시사한다.

Keywords

References

  1. Paras MV, Skevaki CL, Kafetzis DA. Preterm birth due to maternal infection: causative pathogens and models of prevention. Eur J Clin Microbiol Infect Dis 2006;25;562-9 https://doi.org/10.1007/s10096-006-0190-3
  2. Anagrius C, Lore B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005;81;458-62 https://doi.org/10.1136/sti.2004.012062
  3. Kataoka S, Yamada T, Chou K, Nishida R, Morikawa M, Minami M, et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol 2006; 44:51-5 https://doi.org/10.1128/JCM.44.1.51-55.2006
  4. Witt A, Berger A, Gruber CJ, Petricevic L, Apfalter P, Worda C, et al. Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol 2005;193:1663-9 https://doi.org/10.1016/j.ajog.2005.03.067
  5. Harada K. Tanaka H, Komori S. Tsuji Y, Nagata K, Tsutsui H, et al. Vaginal infection with Urea-plasma urealyticum accounts for preterm delivery via induction of inflammatory responses.Microbiol Immunol 2008;52:297-304. https://doi.org/10.1111/j.1348-0421.2008.00039.x
  6. Jelsema R. Ureaplasma associated preterm birth: is there a clinical application? [letter] Am J Obstet Gynecol 2006;195:1493-4.
  7. Sanchez PJ, Regan JA. Vertical transmission of Ureaplasma urealyticum from mothers to preterm infants. Pediatr Infect Dis J 1990;9:398-401. https://doi.org/10.1097/00006454-199006000-00006
  8. Waites KB, Crouse DT, Philips JB 3rd, Canupp KC, Cassell GH. Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn. Pediatrics 1989;83:79-85.
  9. Waites KB, Crouse DT, Cassell GH. Systemic neonatal infection due to Ureaplasma urealyticum. Clin Infect Dis 1993;17 Suppl 1:131-5. https://doi.org/10.1093/clinids/17.Supplement_1.S131
  10. Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 1993;6:69-87. https://doi.org/10.1128/CMR.6.1.69
  11. Veleminsky M, Tosner J. Relationship of vaginal microflora to PROM, pPROM and the risk of early-onset neonatal sepsis. Neuro Endocrinol Lett 2008;29:205-21.
  12. Abele-Horn M, Peters J, Genzel-Boroviczeny O, Wolff C, Zimmermann A, Gottschling W. Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity. Infection 1997;25:286-91. https://doi.org/10.1007/BF01720398
  13. Schelonka RL, Waites KB. Ureaplasma infection and neonatal lung disease. Semin Perinatol 2007; 31:2-9. https://doi.org/10.1053/j.semperi.2007.01.001
  14. Katz B, Patel P, Duffy L, Schelonka RL, Dimmitt RA, Waites KB. Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia. J Clin Microbiol 2005; 43:4852-4. https://doi.org/10.1128/JCM.43.9.4852-4854.2005
  15. Grattard F, Soleihac B, De Barbeyrac B, Bebear C, Seffert P, Pozzetto B. Epidemiologic and molecular investigations of genital mycoplasmas from women and neonates at delivery. Pediatr Infect Dis J 1995;14:853-8. https://doi.org/10.1097/00006454-199510000-00007
  16. Schelonka RL, Katz B, Waites KB, Benjamin DK Jr. Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J 2005;24: 1033-9. https://doi.org/10.1097/01.inf.0000190632.31565.83
  17. Ollikainen J, Korppi M, Heiskanen-Kosma T, Heinonen K. Chronic lung disease of the newborn is not associated with Ureaplasma urealyticum. Pediatr Pulmonol 2001;32:303-7. https://doi.org/10.1002/ppul.1123
  18. Schrag SJ, Hadler JL, Arnold KE, Martell-Cleary P, Reingold A, Schuchat A. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 2006;118:570-6. https://doi.org/10.1542/peds.2005-3083
  19. Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study. BMJ 2002;325(7359):308. https://doi.org/10.1136/bmj.325.7359.308
  20. Lee WR. Neonatal sepsis. J Korean Pediatr Soc 2002:45:289-94.
  21. Philip AG, Hewiit JR. Early diagnosis of neonatal sepsis. Pediatrics 1980;65:1036-41.
  22. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9. https://doi.org/10.1164/ajrccm.163.7.2011060
  23. Kirchner L, Helmer H, Heinze G, Wald M, Brunbauer M, Weninger M, et al. Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants. Eur J Obstet Gynecol Reprod BioI 2007;134:44-50. https://doi.org/10.1016/j.ejogrb.2006.09.013
  24. Volgmann T, Ohlinger R, Panzig B. Ureaplasma urealyticum-harmless commensal or underestimated enemy of human reproduction? A review. Arch Gynecol Obstet 2005;273:133-9. https://doi.org/10.1007/s00404-005-0030-1
  25. Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin MicrobioI Rev 2005;18:757-89. https://doi.org/10.1128/CMR.18.4.757-789.2005
  26. Colaizy TT, Morris CD, Lapidus J, Sklar RS, Pillers DA. Detection of ureaplasma DNA in endotracheal samples is associated with bronchopulmonary dysplasia after adjustment for multiple risk factors. Pediatr Res 2007;61:578-83. https://doi.org/10.1203/pdr.0b013e318045be03
  27. Lim IS, Choi CW, Kim BI, Kim SD, Lee JA, Kim EK, et al. Clinical menifestations of ureaplasma urealyticum colonization in infants. Korean J Perinatol 2007;18:37-44.
  28. Viscardi RM, Manimtim WM, Sun CC, Duffy L, Cassell GH. Lung pathology in premature infants with Ureaplasma urealyticum infection. Pediatr Dev Pathol 2002;5:141-50.
  29. Abele-Horn M, Wolff C, Dressel P, Pfaff F, Zimmermann A. Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease. J Clin Microbiol 1997; 35:1199-202.
  30. Kramer BW, Kallapur S, Newnham J, Jobe AH. Prenatal inflammation and lung development. Semin Fetal Neonatal Med 2009;14:2-7. https://doi.org/10.1016/j.siny.2008.08.011
  31. Goldenberg RL, Andrews WW, Faye-Petersen OM, Goepfert AR, Cliver SP, Hauth JC. The Alabama Preterm Birth Study: intrauterine infection and placental histologic findings in preterm births of males and females less than 32 weeks. Am J Obstet Gynecol 2006;195:1533-7. https://doi.org/10.1016/j.ajog.2006.05.023
  32. Brus F, van Waarde WM, Schoots C, Oetomo SB. Fatal ureaplasmal pneumonia and sepsis in a newborn infant. Eur J Pediatr 1991;150:782-3. https://doi.org/10.1007/BF02026711
  33. Patterson AM, Taciak V, Lovchik J, Fox RE, Campbell AB, Viscardi RM. Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J 1998;17:321-8. https://doi.org/10.1097/00006454-199804000-00011
  34. Glass JI, Lefkowitz EJ, Glass JS, Heiner CR, Chen EY, Cassell GH. The complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature 2000;407:757-62. https://doi.org/10.1038/35037619
  35. Mabanta CG, Pryhuber GS, Weinberg GA, Phelps DL. Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev 2003:CD003744.
  36. Pinna GS, Skevaki CL, Kafetzis DA. The significance of Ureaplasma urealyticum as a pathogenic agent in the paediatric population. Curr Opin Infect Dis 2006;19:283-9. https://doi.org/10.1097/01.qco.0000224824.73223.e7